Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

SyStemix preclinical data

June 5, 1995 7:00 AM UTC

SyStemix Inc. (STMX), Palo Alto Product: Hematopoietic stem cell transplants Indication: Support multiple myeloma patients undergoing chemotherapy Status: Began a Phase I/II trial in 20 patients who w...